The West Virginia Clinical and Translational Science Institute and the Health Sciences Center are pleased to welcome Uwe Staub, Ph.D., chief operating officer with Epigenomics, for a special seminar on Nov. 14.Staub will present, “From the Idea to a Final Product –Translating Targeted Bisulfite Next Generation Sequencing (NGS) on Liquid biopsies into Product on the Market.”
This special seminar will take place tomorrow (Nov. 14) from noon to 1 p.m. in room 2157 of the Health Sciences Center North.
Read the story on the West Virginia Clinical and Translational Science Institute website.